Intelomed
Intelomed Inc. develops non-invasive medical devices for real-time cardiovascular monitoring in the USA.
Founded
2005Intelomed Inc. develops non-invasive medical devices for real-time cardiovascular monitoring in the USA.
Founded in the USA, Intelomed Inc. is dedicated to developing non-invasive medical devices aimed at real-time cardiovascular monitoring. The company's core mission is to enhance patient care through innovative technology that provides accurate and immediate health data. Intelomed's flagship product leverages patented algorithms for biometric data and facial detection technology, integrated with everyday visualization devices such as computers, tablets, and phones. Their market focus is on telehealth solutions, aiming to revolutionize remote patient monitoring and virtual healthcare appointments.
Intelomed has garnered attention from notable healthcare professionals and investors who recognize the potential of their technology to transform telemedicine. Their key achievements include the successful development and deployment of their advanced telehealth platform, which has been praised for its accuracy and user-friendly interface. The overall impact of Intelomed's innovations is significant, as they provide critical real-time health insights that improve patient outcomes and streamline healthcare delivery.
Companies similar to Intelomed include Avicena, Steth IO, Intellimedix and BioIntelliSense.
Intelomed was founded in 2005.
Intelomed's headquarters is located in Wexford, PA, US.
Intelomed's most recent funding round was for $10k (USD) in April 2018.
As of Apr 30, 2018, Intelomed has disclosed funding of $12.7M (USD). Undisclosed round amounts are excluded.
Intelomed has 11 employees as of Feb 5, 2024.
BioIntelliSense
